InvestorsHub Logo
Followers 62
Posts 1712
Boards Moderated 0
Alias Born 08/08/2005

Re: entdoc post# 80194

Thursday, 05/24/2012 10:12:16 AM

Thursday, May 24, 2012 10:12:16 AM

Post# of 345783
Entdoc, thanks for your, always, informative observations. I agree, there is a large body of Peregrine trial data now coming to maturity and this should be very powerful and persuasive.

Bavi has been showing great safety and efficacy in the trial results we have seen, and are now seeing in the new data from the second-line lung cancer (NSCLC) trial. You have also previously written about the potential of attaching enhancing elements to bavituximab: (arming) the basic bavi mAb. I would be interested in anything you can say about the possible variety of armed mAbs that might be employed when you have the time.

sunstar
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News